![(2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide](https://static.cymitquimica.com/products/3D/img/FC102623.png "Cliquez pour agrandir")
(2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
CAS : 1202044-20-9
Ref. 3D-FC102623
| 5mg | À demander | ||
| 10mg | À demander | ||
| 25mg | À demander |
Informations sur le produit
- ((2R)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide)
- GTx-024
- Mk-2866
- (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
- Ostarine(MK-2866)
(2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide is an androgen receptor antagonist that blocks the binding of the natural hormone to its receptor. This drug is used in cancer treatment trials as a monoclonal antibody that binds to the androgen receptor on cancer cells. It has also been shown to have anti-inflammatory properties. (2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide has been shown to cause side effects such as an increased risk of prostate cancer and breast cancer. The drug also causes adverse reactions such as weight gain, high blood pressure,
Propriétés chimiques
Question d’ordre technique sur : 3D-FC102623 (2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
